Class information for:
Level 1: CANCER IMMUNOLOGY IMMUNOTHERAPY//ANTITUMOR CYTOTOXIC LYMPHOCYTES//THYMIC IMMUNE REACTIVITY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
11429 982 31.0 46%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
210 3       IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS 51916
2020 2             CELLULAR IMMUNOLOGY//IMMUNOLOGY//EPICUTANEOUS IMMUNIZATION 5452
11429 1                   CANCER IMMUNOLOGY IMMUNOTHERAPY//ANTITUMOR CYTOTOXIC LYMPHOCYTES//THYMIC IMMUNE REACTIVITY 982

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER IMMUNOLOGY IMMUNOTHERAPY journal 111986 13% 3% 125
2 ANTITUMOR CYTOTOXIC LYMPHOCYTES authKW 62187 0% 100% 2
3 THYMIC IMMUNE REACTIVITY authKW 62187 0% 100% 2
4 ANTIGEN SHEDDING authKW 51816 1% 33% 5
5 ADOPTIVE CHEMOIMMUNOTHERAPY authKW 41457 0% 67% 2
6 DRUG RESISTANT TUMORS authKW 41457 0% 67% 2
7 DOUBLE GRAFTED TUMOR SYSTEM authKW 34976 0% 38% 3
8 6 MERCAPTAPURINE 6 MP authKW 31094 0% 100% 1
9 6 MERCAPTOPURINE DERIVATIVES authKW 31094 0% 100% 1
10 ACTIVE SPECIFIC CHEMOIMMUNOTHERAPY authKW 31094 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Immunology 9475 47% 0% 462
2 Oncology 8505 48% 0% 473
3 Medicine, Research & Experimental 229 7% 0% 67
4 Pharmacology & Pharmacy 225 11% 0% 111
5 Transplantation 86 2% 0% 23
6 CYTOLOGY & HISTOLOGY 58 0% 0% 4
7 Pathology 51 3% 0% 27
8 Allergy 46 1% 0% 12
9 Cell Biology 44 6% 0% 55
10 Hematology 20 2% 0% 22

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANC DRUG GRACE 347 31094 0% 100% 1
2 ENGN DRUGGABLE GENE PROT SCREENIN 31094 0% 100% 1
3 EXTREME BODY CONDIT STUDY 31094 0% 100% 1
4 IMMUNOL INERNAL DIS 31094 0% 100% 1
5 MICROBIOL IMMUNOL MC 790 BOX 6998 31094 0% 100% 1
6 N N BLOKHIN RUSSIAN CANC 31094 0% 100% 1
7 PROGRAMA MAESTRIA CIENCIAS MEDICASIMSS 31094 0% 100% 1
8 UNIT 442CHILDRENS CANC HOSP 31094 0% 100% 1
9 CUALTOS 25436 0% 27% 3
10 GRACE CANC DRUG 15845 1% 5% 10

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 111986 13% 3% 125
2 INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY 16673 3% 2% 33
3 GANN 9349 2% 2% 15
4 CANCER RESEARCH 8229 10% 0% 102
5 EKSPERIMENTALNAYA ONKOLOGIYA 4226 1% 1% 13
6 CELLULAR IMMUNOLOGY 4041 3% 0% 32
7 JAPANESE JOURNAL OF CANCER RESEARCH 3139 2% 1% 19
8 CLINICS IN IMMUNOLOGY AND ALLERGY 3026 0% 2% 4
9 JOURNAL OF IMMUNOLOGY 3018 7% 0% 73
10 IMMUNOPHARMACOLOGY 2811 1% 1% 11

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 ANTITUMOR CYTOTOXIC LYMPHOCYTES 62187 0% 100% 2 Search ANTITUMOR+CYTOTOXIC+LYMPHOCYTES Search ANTITUMOR+CYTOTOXIC+LYMPHOCYTES
2 THYMIC IMMUNE REACTIVITY 62187 0% 100% 2 Search THYMIC+IMMUNE+REACTIVITY Search THYMIC+IMMUNE+REACTIVITY
3 ANTIGEN SHEDDING 51816 1% 33% 5 Search ANTIGEN+SHEDDING Search ANTIGEN+SHEDDING
4 ADOPTIVE CHEMOIMMUNOTHERAPY 41457 0% 67% 2 Search ADOPTIVE+CHEMOIMMUNOTHERAPY Search ADOPTIVE+CHEMOIMMUNOTHERAPY
5 DRUG RESISTANT TUMORS 41457 0% 67% 2 Search DRUG+RESISTANT+TUMORS Search DRUG+RESISTANT+TUMORS
6 DOUBLE GRAFTED TUMOR SYSTEM 34976 0% 38% 3 Search DOUBLE+GRAFTED+TUMOR+SYSTEM Search DOUBLE+GRAFTED+TUMOR+SYSTEM
7 6 MERCAPTAPURINE 6 MP 31094 0% 100% 1 Search 6+MERCAPTAPURINE+6+MP Search 6+MERCAPTAPURINE+6+MP
8 6 MERCAPTOPURINE DERIVATIVES 31094 0% 100% 1 Search 6+MERCAPTOPURINE+DERIVATIVES Search 6+MERCAPTOPURINE+DERIVATIVES
9 ACTIVE SPECIFIC CHEMOIMMUNOTHERAPY 31094 0% 100% 1 Search ACTIVE+SPECIFIC+CHEMOIMMUNOTHERAPY Search ACTIVE+SPECIFIC+CHEMOIMMUNOTHERAPY
10 ACUTE MORBILLI INFECTION 31094 0% 100% 1 Search ACUTE+MORBILLI+INFECTION Search ACUTE+MORBILLI+INFECTION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BEN-EFRAIM, S , (2001) IMMUNOMODULATING ANTICANCER ALKYLATING DRUGS: TARGETS AND MECHANISMS OF ACTIVITY.CURRENT DRUG TARGETS. VOL. 2. ISSUE 2. P. 197 -212 65 76% 19
2 EHRKE, MJ , (2003) IMMUNOMODULATION IN CANCER THERAPEUTICS.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 3. ISSUE 8. P. 1105-1119 45 63% 51
3 EHRKE, MJ , MIHICH, E , BERD, D , MASTRANGELO, MJ , (1989) EFFECTS OF ANTICANCER DRUGS ON THE IMMUNE-SYSTEM IN HUMANS.SEMINARS IN ONCOLOGY. VOL. 16. ISSUE 3. P. 230-253 45 74% 70
4 CLAESSEN, AME , VALSTER, H , BRIL, H , STEERENBERG, PA , TAN, BTG , SCHEPER, RJ , (1991) TUMOR-REGRESSION AND INDUCTION OF ANTITUMOR IMMUNITY BY LOCAL CHEMOTHERAPY OF GUINEA-PIGS BEARING A LINE-10 HEPATOCARCINOMA.INTERNATIONAL JOURNAL OF CANCER. VOL. 47. ISSUE 4. P. 626-632 28 93% 4
5 INGE, TH , HOOVER, SK , FRANK, JL , KAWABATA, TT , BETHKE, KP , BEAR, HD , (1992) ENHANCEMENT OF CYTOTOXIC LYMPHOCYTE-T GROWTH FROM SPLEENS OF P815-TUMOR-BEARING HOST MICE WITH MAFOSFAMIDE.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 35. ISSUE 2. P. 119-126 24 83% 13
6 FUJIWARA, H , HAMAOKA, T , (1988) CELLULAR MECHANISMS OF TUMOR REJECTION INVIVO AND ENHANCED INDUCTION OF ANTI TUMOR PROTECTIVE IMMUNITY APPLICABLE TO TUMOR-SPECIFIC IMMUNOTHERAPY.PROGRESS IN EXPERIMENTAL TUMOR RESEARCH. VOL. 32. ISSUE . P. 69-103 35 65% 0
7 NORTH, RJ , (1985) DOWN-REGULATION OF THE ANTITUMOR IMMUNE-RESPONSE.ADVANCES IN CANCER RESEARCH. VOL. 45. ISSUE . P. 1-43 35 58% 174
8 WEISKIRCH, LM , MOKYR, MB , (1992) SOME APPROACHES TO IMPROVE THE THERAPEUTIC EFFECTIVENESS OF ADOPTIVE CHEMOIMMUNOTHERAPY WITH SPLEEN-CELLS FROM MELPHALAN-TREATED BALB/C MICE BEARING A LARGE MOPC-315 TUMOR.INTERNATIONAL JOURNAL OF CANCER. VOL. 51. ISSUE 1. P. 84-92 18 100% 2
9 MOKYR, MB , DRAY, S , (1987) INTERPLAY BETWEEN THE TOXIC EFFECTS OF ANTICANCER DRUGS AND HOST ANTITUMOR IMMUNITY IN CANCER-THERAPY.CANCER INVESTIGATION. VOL. 5. ISSUE 1. P. 31-38 27 79% 30
10 BARTIK, MM , BAUMGARTELSCOFIELD, BA , MOKYR, MB , (1991) ENHANCED EXPANSION OF THE THYMIC CD8+ CELL SUBSET AS A POTENTIAL MECHANISM FOR THE GENERATION OF ENHANCED ANTITUMOR CYTOTOXICITY BY THYMOCYTES FROM LOW-DOSE MELPHALAN-TREATED MOPC-315 TUMOR BEARERS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 34. ISSUE 2. P. 79-89 22 79% 3

Classes with closest relation at Level 1


Rank Class id link
1 19255 ARTIFICIAL BOUNDARY LIPID//CD8 CELL REACTIVITY//SUBCELLULAR TOPOLOGY
2 36657 HUMAN LARYNGEAL CANCER CELL CULTURE//MED CLIN HOSP REBRO NUCL MED//MED CLIN HOSP REBRO RADIOL
3 33910 MU MSV//ANATTRAUMA GRP//BONE ABSORPTIOMETRY DEXA
4 7508 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL
5 29868 CONCOMITANT RESISTANCE//MURINE LEUKAEMIA//ESTUDIOS ONCOL
6 34944 DENT ORAL SURG 2 HIGASHI KU//P 53 ASSAY//THYMOCYTES DIFFERENTIATION
7 17208 NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY ASI//ACTIVE SPECIFIC IMMUNOTHERAPY
8 16597 ANTIGEN ADMINISTRATION ROUTE//ANTIGEN EXPRESSION MHC//ANTIGEN PRESENTATION PATHWAY
9 32952 NOCARDIA OPACA//ACHYRANTHES BIDENTATA POLYSACCHARIDES ABPS//IN VITRO RESPONSE TO NDCM
10 25687 IMMUNOSUPPRESSIVE MACROPHAGES//T CELL MITOGENESIS//MYCOBACTERIUM LEPRAEMURIUM

Go to start page